Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.50
-0.25 (-0.79%)
Sep 8, 2026, 1:30 PM CST

Nang Kuang Pharmaceutical Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,1092,1622,2002,1501,9401,780
Revenue Growth
-7.50%-1.71%2.31%10.81%9.01%1.44%
Gross Profit
734.2768.86747.79755.56694.9594.47
Operating Income
261.23295.67310.22259.84321.67254.48
Net Income
205.39244.41243.41198.41352196.11
Earnings Per Share
2.032.412.401.963.481.94
EPS Growth
-23.07%0.42%22.45%-43.68%79.38%7.18%

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Countries
10.9667.664.3154.4534.8226.62
Taiwan
1,7071,7031,6121,4211,3061,173
Mainland China
-209.24239.74407.41184.15362.6
Japan
-101.06190.08207.07240.9395.64
United States
-81.4593.2460.37174.14122.59
Total
2,1092,1622,2002,1501,9401,780

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
363.56345.67301.54378.48402.51418.41
Total Debt
684.35655.69638.23705.56409.13532.81
Net Cash (Debt)
-320.8-310.02-336.69-327.08-6.62-114.4
Net Cash Growth
------
Net Cash Per Share
-3.17-3.06-3.33-3.23-0.07-1.13

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
351.2464.08466.43342.61369.19556.63
Capital Expenditures
-206.54-277.82-524.6-297.51-93.84-156.05
Free Cash Flow
144.66186.25-58.1745.1275.35400.58
Free Cash Flow Growth
58.82%---83.62%-31.26%558.08%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
34.81%35.56%33.99%35.14%35.81%33.40%
Operating Margin
12.38%13.67%14.10%12.08%16.58%14.30%
Pretax Margin
11.52%13.47%13.78%9.94%21.16%13.19%
Profit Margin
9.74%11.30%11.06%9.23%18.14%11.02%
FCF Margin
6.86%8.61%-2.64%2.10%14.19%22.50%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.600-1.6002.0002.3001.800
Dividend Per Share Growth
0%--20.00%-13.04%27.78%12.50%
Dividend Yield
5.09%-4.27%4.28%4.26%5.82%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
15.5115.4117.0727.1318.3319.83
Forward PE
-14.9217.9519.6821.3014.55
P/FCF Ratio
21.9920.22-119.3623.449.71
PS Ratio
1.511.741.892.503.332.18